Madrigal Pharmaceuticals, Inc. MDGL Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s price / sales?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported price / sales of 10.6× in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s price / sales changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s price / sales decreased by 54.0% year-over-year, from 23× to 10.6×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.